Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
This study tests whether adding an immunotherapy drug (PD-1 inhibitor) to chemotherapy before standard treatment can help people with advanced nasopharyngeal cancer live longer without the disease getting worse. About 150 adults with stage T4 or N2-3 cancer will receive either th…
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 17, 2026 02:05 UTC